City of Geneva, Alabama v. Purdue Pharma L.P. et al
| City of Geneva, Alabama |
| Ortho-McNeil-Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica, Inc., McKesson Corporation, Endo Health Solutions, Inc., Purdue Pharma L.P., Mallinckrodt LLC, Purdue Pharma, Inc., Teva Pharmaceutical Industries, LTD., Allergan PLC, TEVA Pharmaceuticals USA, Inc., Endo Pharmaceuticals, Inc., Cardinal Health, Inc., Actavis, LLC, Actavis Pharma, Inc., Watson Laboratories, Inc., Cephalon, Inc., The Purdue Frederick Company, Inc., Johnson & Johnson, Watson Pharmaceuticals, Inc., Amerisourcebergen Drug Corporation, Janssen Pharmaceuticals, Inc., Noramco, Inc., Janssen Pharmaceuticals, Mallinckrodt, PLC, Actavis Inc., Actavis PLS and Watson Pharma, Inc. |
| 1:2019cv00763 |
| October 9, 2019 |
| US District Court for the Middle District of Alabama |
| Wallace Capel |
| Emily C Marks |
| Racketeer/Corrupt Organization |
| 18 U.S.C. § 1961 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 7, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Received email from OHND regarding receipt of e-transfer case; OHND case number assigned as 1:19-op-45986. (No pdf attached to this entry) (kr, ) |
| Filing 21 Received certified copy of Conditional Transfer Order entered on 10/30/2019 by the Judicial Panel on Multidistrict Litigation transferring this action to USDC for the Northern District of Ohio. (kr, ) |
| Case transferred to Northern District of Ohio; Electronically transferred via CM/ECF transfer to Clerk. (No pdf attached to this entry) (kr, ) |
| Filing 20 Return Receipt Card showing service of Summons, #1 Complaint & #2 Corporate/Conflict Disclosure Statement signed by (No Signature) for Endo Health Solutions, Inc. served on 10/22/2019, answer due 11/12/2019. (kr, ) |
| Filing 19 Return Receipt Card showing service of Summons, #1 Complaint & #2 Corporate/Conflict Disclosure Statement signed by (Illegible) for Purdue Pharma, Inc. served on 10/22/2019, answer due 11/12/2019. (kr, ) |
| Filing 18 Return Receipt Card showing service of Summons, #1 Complaint & #2 Corporate/Conflict Disclosure Statement signed by Marilyn (Illegible) for Watson Laboratories, Inc. served on 10/25/2019, answer due 11/15/2019. (kr, ) |
| Filing 17 Return Receipt Card showing service of Summons, #1 Complaint & #2 Corporate/Conflict Disclosure Statement signed by (Illegible) for Cephalon, Inc. served on 10/21/2019, answer due 11/12/2019. (kr, ) |
| Filing 16 Return Receipt Card showing service of Summons, #1 Complaint & #2 Corporate/Conflict Disclosure Statement signed by (Illegible) for Cardinal Health, Inc. served on 10/21/2019, answer due 11/12/2019. (kr, ) |
| Filing 15 Return Receipt Card showing service of Summons, #1 Complaint & #2 Corporate/Conflict Disclosure Statement signed by (Illegible) for Johnson & Johnson served on 10/21/2019, answer due 11/12/2019. (kr, ) |
Filing 14
ORDER: it is ORDERED that the #13 Unopposed Motion for an Extension of Time is GRANTED; The Defendants shall have sixty (60) days after a decision is issued on that transfer of this case to the MDL No. 2804, In re: National Prescription Opiate Litigation, to file an answer or otherwise respond to the Complaint. Signed by Chief Judge Emily C. Marks on 10/23/2019. (kr, )
|
| Filing 13 Unopposed MOTION for Extension of Time to Respond to the Complaint by Amerisourcebergen Drug Corporation, Cardinal Health, Inc., McKesson Corporation. (Strubel, John) Modified on 10/23/2019 to clarify text (kr, ). |
| Filing 12 Return Receipt Card showing service of #1 Compliant & #3 Summons signed by Julie Buckner for Actavis Pharma, Inc., TEVA Pharmaceuticals USA, Inc served on 10/17/2019, answer due 11/7/2019. (cnw, ) |
| Filing 11 Corporate/Conflict Disclosure Statement by Amerisourcebergen Drug Corporation. (Strubel, John) |
| Filing 10 NOTICE of Appearance by John Patrick Strubel on behalf of Amerisourcebergen Drug Corporation (Strubel, John) |
| Filing 9 Return Receipt Card showing service of #1 Compliant & #3 Summons signed by Kelly Webster for McKesson Corporation, Purdue Pharma L.P., served on 10/16/2019, answer due 11/6/2019. (cnw, ) |
| Filing 8 Return Receipt Card showing service of #1 Compliant & #3 Summons signed by illegible for Actavis, LLC served on 10/18/2019, answer due 11/8/2019. (cnw, ) |
| Filing 7 Return Receipt Card showing service of #1 Compliant & #3 Summons signed by Paul Sisofo for The Purdue Frederick Company, Inc., served on 10/18/2019, answer due 11/8/2019. (cnw, ) |
| Filing 6 NOTICE of Appearance by David Lee Brown, Jr on behalf of Amerisourcebergen Drug Corporation (Brown, David) |
| Filing 5 NOTICE of Appearance by Houston Lanier Brown, II on behalf of Amerisourcebergen Drug Corporation (Brown, Houston) |
| Filing 4 Return Receipt Card showing service of #1 Complaint, #3 Summons signed by Jennifer Lockwood for Amerisourcebergen Drug Corporation, Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Noramco, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc. served on 10/16/2019, answer due 11/6/2019. (cnw, ) |
| Filing 3 Summons Issued as to Actavis Pharma, Inc., Actavis, LLC, Amerisourcebergen Drug Corporation, Cardinal Health, Inc., Cephalon, Inc., Endo Health Solutions, Inc., Endo Pharmaceuticals, Inc., Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Mallinckrodt LLC, McKesson Corporation, Noramco, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc., Purdue Pharma L.P., Purdue Pharma, Inc., TEVA Pharmaceuticals USA, Inc., The Purdue Frederick Company, Inc., Watson Laboratories, Inc., Watson Pharmaceuticals, Inc.; mailed CMRRR with copy of #1 Complaint & #2 Corporate/Conflict Disclosure Statement. (cnw, ) |
| Filing 2 Corporate/Conflict Disclosure Statement by City of Geneva, Alabama. (cnw, ) |
| Filing 1 COMPLAINT against Actavis Pharma, Inc., Actavis, LLC, Allergan PLC, Amerisourcebergen Drug Corporation, Cardinal Health, Inc., Cephalon, Inc., Endo Health Solutions, Inc., Endo Pharmaceuticals, Inc., Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Mallinckrodt LLC, Mallinckrodt, PLC, McKesson Corporation, Noramco, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc., Purdue Pharma L.P., Purdue Pharma, Inc., TEVA Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries, LTD., The Purdue Frederick Company, Inc., Watson Laboratories, Inc., Watson Pharmaceuticals, Inc. ( Filing fee $ 400.00 receipt number 4602055228.), filed by City of Geneva, Alabama. (Attachments: #1 Civil Cover Sheet, #2 receipt)(cnw, ) |
| DEMAND for Trial by Jury by City of Geneva, Alabama. (No pdf attached to this entry - see doc #1 for pdf) (cnw, ) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Alabama Middle District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
